UK Apheresis Market (2026-2031)

RESEARCH METHODOLOGY

This study involved the extensive use of both primary and secondary sources. The research process involved examining various factors affecting the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and key players' strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, Companies House documents, investor presentations, and SEC filings. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the apheresis market. It was also used to obtain important information about key players, market classification & segmentation according to industry trends, down to the bottom level, and key developments from market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply & demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the apheresis market. The primary sources from the demand side include medical OEMs, medical device ISOs, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights into key industry trends & key market dynamics.

Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.
Note 2: Others include sales, marketing, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = <USD 50 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

In this report, the global apheresis market size was determined using revenue share analysis of leading players. For this purpose, key market players were identified, and their revenues from the apheresis business were determined using insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, including CEOs, directors, and marketing executives.

To calculate the global market value, segmental revenues were derived from the revenue mapping of major solution/service providers. This process involves the following steps:

• Generating a list of major global players operating in the apheresis market
• Mapping annual revenues generated by major global players from the apheresis segment (or nearest reported business unit/service category)
• Revenue mapping of key players to cover a major share of the global market as of 2025
• Extrapolating the global value of the apheresis industry

Data Triangulation

After arriving at the overall market size through the market size estimation process explained above, the global apheresis market was segmented and subsegmented. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the apheresis market was validated using both top-down and bottom-up approaches.

Market Definition

Apheresis is a medical technology and extracorporeal blood separation procedure in which whole blood is withdrawn from a donor or patient and processed through a device that separates specific blood components. The desired component is collected or treated, while the remaining blood components are returned to the individual. The process primarily uses centrifugation or membrane filtration to separate blood components.

Apheresis encompasses both donor and therapeutic procedures and is widely used in transfusion medicine, hematology, oncology, nephrology, neurology, and immunology for blood component collection and the treatment of various disorders, including autoimmune diseases, hematologic conditions, and metabolic disorders.

Key Stakeholders

• Companies manufacturing apheresis devices & disposables
• Original equipment manufacturing companies
• Suppliers and distributors of apheresis devices & disposables
• Healthcare service providers
• Health insurance payers
• Government bodies/municipal corporations
• Regulatory bodies
• Medical research institutes
• Business research and consulting service providers
• Venture capitalists
• Market research and consulting firms

Report Objectives

• To define, describe, and forecast the global apheresis devices market based on product, type, procedure, technology, end user, and region
• To provide detailed information regarding the major factors influencing the market growth
  (such as drivers, restraints, opportunities, and challenges) along with the current trends
• To strategically analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall apheresis market
• To analyze the opportunities in the global apheresis market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of the market segments concerning five main regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
• To profile the key players and analyze their market shares and core competencies2
• To track and analyze competitive developments, such as product launches, partnerships, agreements, collaborations, expansions, strategic alliances, and acquisitions in the global apheresis market.
• To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy.